Skip to main content

Table 6 ELISpot IFN-γ activity of CSP predicted epitopes after depletion of CD4+ and CD8+ T cells compared with ICS CD8+ and CD4+ T cell IFN-γ activity

From: Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Vol.

Pool

Epitope no.

Sequence

HLA allele group

Control depl. sfc/m

CD8+ depl. sfc/m (%)*

CD4+ depl. sfc/m (%)*

CD8+ %**

CD4+ %**

V401

Cp1

   

97

5 (-95%)

82 (-15%)

0.44

0.02

 

E21

SFLFVEALF

A*23:01

254

15 (-94%)

226 (-11%)

0.37

0.04

 

E14

SVFNVVNSSI

A*23:01

86

38 (-56%)

43 (-50%)

0.12

0.01

 

E18

LIMVLSFLF

A*23:01

236

23 (-90%)

210 (-11%)

0.54

0.02

V692

Cp1

   

445

6 (-98%)

397 (-11%)

0.53

0.01

 

E2

FVEALFQEY

B*35:01

380

17 (-96%)

356 (-6%)

0.48

0.00

V1253

 

E20

SVSSFLFV EA

A*02:01

79

72 (-9%)

17 (-78%)

0.06

0.02

V1563

Cp1

   

133

0 (-100%)

135 (+2%)

0.33

0.01

 

E21

SFLFVEALF

A*29:02

213

29 (-86%)

273 (+28%)

0.25

0.01

 

E1

FLFVEALFQ E

A*29:02

245

91 (-73%)

215 (-12%)

0.34

0.03

 

Cp9

E18

LIMVLSFLF

A*29:02

307

85 (-82%)

264 (-18%)

0.26

0.01

  1. 1PBMC from one month after the first Ad-C immunization; 2PBMC from 19 days after the second Ad-C immunization; 3PBMC from 28 days after challenge following Ad-CA immunization.
  2. *The percent change in ELISpot activity is shown after depletion of CD4+ or CD8+ T cells.
  3. **The percent of CD8+ or CD4+ gated T cells expressing IFN-γ.
  4. depl. = depletion.
  5. sfc/m = spot forming cells/million.
  6. v125 did not have sufficient PBMC to test Cp1.